EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.2.1.114 | Leukemia |
1399150 |
The presence of concanavalin-A(Con-A)-like molecules on natural-killer (NK)-sensitive target cells: their possible role in swainsonine-augmented human NK cytotoxicity. |
ongoing research
therapeutic application
unassigned |
1
3
0 |
| 3.2.1.114 | Leukemia |
3161732 |
Sensitivity to alpha/beta-interferon is independent of N-linked complex-type oligosaccharides on cell-surface-membrane glycoproteins. |
ongoing research
unassigned |
2
0 |
| 3.2.1.114 | Lung Neoplasms |
32723834 |
Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human Tumors. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
2
4
0 |
| 3.2.1.114 | Lymphoma |
3023355 |
N-glycosylation in expression and function of beta-adrenergic receptors. |
ongoing research
unassigned |
3
0 |
| 3.2.1.114 | Lysosomal Storage Diseases |
12417404 |
Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 3.2.1.114 | Lysosomal Storage Diseases |
24758700 |
Swainsonine-containing plants and their relationship to endophytic fungi. |
unassigned |
0 |
| 3.2.1.114 | Lysosomal Storage Diseases |
27085305 |
A swainsonine survey of North American Astragalus and Oxytropis taxa implicated as locoweeds. |
causal interaction
unassigned |
2
0 |
| 3.2.1.114 | Lysosomal Storage Diseases |
27644899 |
Fungicide treatment and clipping of Oxytropis sericea does not disrupt swainsonine concentrations. |
causal interaction
unassigned |
3
0 |
| 3.2.1.114 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase deficiency |
12417404 |
Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 3.2.1.114 | Melanoma |
32723834 |
Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human Tumors. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
2
4
0 |
